• Cystatin C proteoforms in chronic kidney disease 

      Dahl, Helene; Meyer, Klaus; Sandnes, Kristina; Welland, Natasha Lervaag; Arnesen, Iselin; Marti, Hans Peter; Dierkes, Jutta; Lysne, Vegard (Journal article; Peer reviewed, 2023)
      Cystatin C, a cysteine protease inhibitor, is used as a biomarker of renal function. It offers several advantages compared to creatinine, and formulas for the estimation of the glomerular filtration rate based on cystatin ...
    • High rates of central obesity and sarcopenia in CKD irrespective of renal replacement therapy - An observational cross-sectional study 

      Dierkes, Jutta; Dahl, Helene; Welland, Natasha Lervaag; Sandnes, Kristina; Sæle, Kristin; Sekse, Ingegjerd; Marti, Hans-Peter (Journal article; Peer reviewed, 2018-10-11)
      Background: Poor nutritional status of patients with renal disease has been associated with worsening of renal function and poor health outcomes. Simply measuring weight and height for calculation of the body mass index ...
    • Medication Prescription, Common Side-effects, and Nutritional Status are Associated in Patients With Chronic Kidney Disease 

      Dahl, Helene; Sandblost, Silje Regine Thue; Welland, Natasha Lervaag; Sandnes, Kristina; Sekse, Ingegjerd; Sæle, Kristin; Marti, Hans Peter; Holst, Lone; Dierkes, Jutta (Journal article; Peer reviewed, 2022)
      Objective Chronic kidney disease (CKD) is associated with metabolic, nutritional, and extra-renal changes, as well as a high rate of comorbidities, which necessitates the prescription of numerous medications. Patients ...